AtaCor raises $75m for trial of EV-ICD system
The US FDA study is intended to evaluate the system for treating life-threatening ventricular tachyarrhythmias.
07 October 2025
07 October 2025
The US FDA study is intended to evaluate the system for treating life-threatening ventricular tachyarrhythmias.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.